✦ LIBER ✦

AS-31: Angiographic Outcomes of Zotarolimus- vs Sirolimus- vs Paclitaxel-Eluting Stent for Native Coronary Arteries: Angiographic Substudy of the ZEST Trial

✍ Scribed by Young-Hak Kim; Won-Jang Kim; Sung-Cheol Yun; Jong-Young Lee; Duk-Woo Park; Seung-Whan Lee; Cheol Whan Lee; Myeong-Ki Hong; Seong-Wook Park; Seung-Jung Park

Book ID: 113445518
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 29 KB
Volume: 103
Category: Article
ISSN: 0002-9149
DOI: 10.1016/j.amjcard.2009.01.073

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

AS-149: Angiographic Outcomes of Zotarol

AS-149: Angiographic Outcomes of Zotarolimus-, Sirolimus-, and Paclitaxel-Eluting Stents for Native Coronary Arteries: Angiographic Study of the ZEST Trial

✍ Young-Hak Kim; Duk-Woo Park; Sung-Cheol Yun; Soo-Jin Kang; Seung-Whan Lee; Cheol 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 80 KB

TCT-410: I-LOVE-IT - A Prospective, Mult

TCT-410: I-LOVE-IT - A Prospective, Multicenter Clinical Trial of TIVOLI Bioabsorbable Polymer Based Sirolimus-Eluting vs. ENDEAVOR Zotarolimus-Eluting Stent in Patients with Coronary Artery Disease: 8-Month Angiographic and 1-Year Clinical Follow-Up Results

📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 185 KB

Impact of drug-eluting stent selection o

Impact of drug-eluting stent selection on long-term clinical outcomes in patients treated for unprotected left main coronary artery disease: The sirolimus vs paclitaxel drug-eluting stent for left main registry (SP-DELFT)

✍ E. Meliga; H.M. Garcia-Garcia; M. Valgimigli; A. Chieffo; G. Biondi-Zoccai; A.O. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 282 KB